|
Type 2 diabetes
University of Iowa Hospitals and Clinics is one of 70
centers taking part in a new nationwide study to test three
promising approaches to lower the risk of heart disease and
stroke in adults with Type 2 diabetes. The Action to Control
Cardiovascular Risk in Diabetes (ACCORD) study is being
funded by the National Heart, Lung, and Blood Institute,
part of the National Institutes of Health. Patients with
Type 2 diabetes who volunteer to participate will undergo a
variety of tests to determine if they are eligible. For more
information, call Sheila Wayson, nurse clinician and trial
coordinator, toll free at (877) 807-9590 or at (319)
356-4879 and ask about the ACCORD study.
Atherosclerosis
People ages 55 to 90 who have atherosclerosis (deposits
of fatty substances or other material that narrow or block
blood vessels) are invited to participate in a University of
Iowa Health Care study. The study will improve society's
understanding of how blood vessel function relates to
cognition (the ability to remember things, pay attention,
learn, and solve problems). Volunteers must have at least
one of the following conditions: atherosclerosis (blockage
of the blood vessels), claudication (peripheral vascular
disease), angina, previous heart attack, angioplasty, or
stent placement. Compensation is available. David Moser,
Ph.D., assistant professor of psychiatry, leads the UI
portion of the study. For more information, call Becky
Reese, research assistant, at (319) 353-4276.
Memory problems
People age 62 and older who are experiencing mild memory
problems are invited to participate in a University of Iowa
Health Care study to evaluate the effectiveness of
medications that may benefit memory. Eligible participants
must otherwise be healthy. The study will evaluate the
effectiveness of donepezil (Aricept) and the herbal
supplement ginkgo biloba extract as compared to placebo
(inactive substance) on brain function and blood flow. All
tests and study medications will be provided free.
Compensation for travel and parking costs also is available.
The UI portion of the study is led by Susan Schultz, M.D.,
associate professor of psychiatry. For more information,
contact Karen Ekstam Smith, research nurse, at (319)
353-5158.
|
|